Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques.

It has been widely hypothesized that the ovarian steroids, estrogen (E) and progesterone (P), act on serotonin neurons to modulate mood and increase prolactin secretion in women. However, information is needed on the molecular consequences of ovarian hormone action in serotonin neurons. This study examined the effect of E and P on the expression of mRNA for the serotonin re-uptake transporter (SERT) in monkeys using in situ hybridization and a 253 bp human SERT cRNA probe. Monkeys (n=5 animals/group) were ovariectomized and hysterectomized (spayed) and then untreated (control), or treated, with E for 28 days (E treated) or treated with E for 28 days and supplemented with P for the last 14 days of the E regimen (E+P treated). Densitometric analysis of autoradiographs with gray-level thresholding was performed at five levels of the dorsal and median raphe. The number of pixels exceeding background in defined areas was obtained (pixel number). The average pixel number for spayed, E- and E+P-treated groups was 22 280+/-3517, 15 227+/-1714, and 14 827+/-2042, respectively, in the combined dorsal and median raphe. In the E- and E+P-treated groups compared to the control group, there was a 32% and 33% decrease in SERT mRNA signal represented by pixel number (ANOVA, P<0.05). Hence, E- and E+P-treated groups were significantly less than the control group, but they were not different from one another. Also, there were significantly fewer SERT mRNA-positive cells in the dorsal raphe of E- and E+P-treated groups (ANOVA, P<0.001). Therefore E, with or without P, reduces SERT mRNA expression. These results suggest that the ability of P to increase prolactin secretion in E-primed monkeys does not involve an action at the level of SERT gene transcription. Hence, the mechanism by which the CNS transduces the action of P on prolactin secretion remains to be elucidated. However, these data suggest that one action of E replacement therapy in postmenopausal women may be to decrease expression of the SERT gene.

[1]  U. Knigge,et al.  Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. , 1992, Neuroendocrinology.

[2]  P. Blockx,et al.  Sex‐linked differences in cortisol, ACTH and prolactin responses to 5‐hydroxy‐tryptophan in healthy controls and minor and major depressed patients , 1989, Acta psychiatrica Scandinavica.

[3]  Abraham Weizman,et al.  Upregulation of imipramine binding and serotonin uptake by estradiol in female rat brain , 1987, Brain Research.

[4]  P. Webb,et al.  Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. , 1995, Molecular endocrinology.

[5]  L. Schneider,et al.  Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. , 1997, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[6]  J D Baxter,et al.  The nuclear hormone receptor gene superfamily. , 1995, Annual review of medicine.

[7]  R. Blakely,et al.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Studd,et al.  Transdermal oestrogen for treatment of severe postnatal depression , 1996, The Lancet.

[9]  Lasley,et al.  Characterization of the onset of menopause in the rhesus macaque. , 1997, Biology of reproduction.

[10]  B. Ulfhake,et al.  Increased expression of serotonin transporter messenger RNA in raphe neurons of the aged rat. , 1995, Brain research. Molecular brain research.

[11]  I. Törk.  30 – Raphe Nuclei and the Serotonergic System , 1990 .

[12]  M. Maes,et al.  HPA-Axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[13]  G. Jahn,et al.  A possible dual regulation of prolactin release by the serotoninergic system in rats at pro-oestrus and during late pregnancy: role of ovarian hormones. , 1987, Journal of Endocrinology.

[14]  G. Oppenheim.  Estrogen in the treatment of depression: neuropharmacological mechanisms. , 1983, Biological psychiatry.

[15]  R. Brenner,et al.  Regulation and localization of estrogen and progestin receptors in the pituitary of steroid-treated monkeys. , 1990, Endocrinology.

[16]  G. Hodgen,et al.  Hyperprolactinemia induced by an estrogen-progesterone synergy: quantitative and temporal effects of estrogen priming in monkeys. , 1985, The Journal of clinical endocrinology and metabolism.

[17]  U. Halbreich,et al.  Altered Serotonergic Activity in Women with Dysphoric Premenstrual Syndromes , 1993, International journal of psychiatry in medicine.

[18]  J. Turcotte,et al.  Estradiol-induced progestin receptor immunoreactivity is found only in estrogen receptor-immunoreactive cells in guinea pig brain. , 1989, Neuroendocrinology.

[19]  L. D. van de Kar,et al.  Neuroendocrine Pharmacology of Serotonergic (5-HT) Neurons , 1991 .

[20]  C. Bethea,et al.  RU 486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys. , 1997, Neuroendocrinology.

[21]  L. Siever,et al.  Critical issues in defining the role of serotonin in psychiatric disorders. , 1991, Pharmacological reviews.

[22]  P. Yen.  Dominant Negative Activity by Estrogen and Progesterone Receptors , 1997 .

[23]  J. Clemens.  Neuropharmacological aspects of the neural control of prolactin secretion. , 1976, Current topics in molecular endocrinology.

[24]  Fluoxetine in the Treatment of Premenstrual Dysphoria , 1995 .

[25]  S. Kohama,et al.  Steroid regulation of estrogen and progestin receptor messenger ribonucleic acid in monkey hypothalamus and pituitary. , 1996, Endocrinology.

[26]  B. Katzenellenbogen,et al.  Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. , 1996, Molecular endocrinology.

[27]  S. Kohama,et al.  Ovarian Steroid Regulation of Tryptophan Hydroxylase mRNA Expression in Rhesus Macaques , 1996, The Journal of Neuroscience.

[28]  C. Bethea.  Regulation of progestin receptors in raphe neurons of steroid-treated monkeys. , 1994, Neuroendocrinology.

[29]  M. Gitlin,et al.  Psychiatric syndromes linked to reproductive function in women: a review of current knowledge. , 1989, The American journal of psychiatry.

[30]  D. Murphy,et al.  Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. , 1997, The Journal of clinical endocrinology and metabolism.

[31]  G. Fink,et al.  Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. , 1997, Brain research. Molecular brain research.

[32]  B. Parry.  Psychobiology of premenstrual dysphoric disorder. , 1997, Seminars in reproductive endocrinology.

[33]  J. Voogt,et al.  Serotonin-induced decrease in hypothalamic tyrosine hydroxylase activity and corresponding increase in prolactin release are abolished at midpregnancy and by transplants of rat choriocarcinoma cells. , 1992, Endocrinology.

[34]  E. Palazidou,et al.  Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release. , 1994, European journal of pharmacology.

[35]  L. D. van de Kar,et al.  Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion. , 1989, The Journal of pharmacology and experimental therapeutics.

[36]  M. Weissman,et al.  Gender and depression , 1985, Trends in Neurosciences.

[37]  M. Majewska,et al.  Neurosteroids: Endogenous bimodal modulators of the GABAA receptor mechanism of action and physiological significance , 1992, Progress in Neurobiology.

[38]  P. Cowen,et al.  Decreased 5-HT-Mediated Prolactin Release in Major Depression , 1992, British Journal of Psychiatry.

[39]  J. Mortola.  A Risk-Benefit Appraisal of Drugs Used in the Management of Premenstrual Syndrome , 1994, Drug safety.

[40]  K. Kellar,et al.  Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin. , 1992, Neuroendocrinology.

[41]  J. Voogt,et al.  Serotonin synthesis inhibition or receptor antagonism reduces pregnancy-induced nocturnal prolactin secretion. , 1990, Life sciences.

[42]  J. Studd,et al.  Transdermal oestrogen for treatment of severe postnatal depression , 1996, The Lancet.

[43]  B. Sherwin,et al.  Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women , 1990, Biological Psychiatry.

[44]  C. McKittrick,et al.  Autoradiographic analyses of the effects of estradiol benzoate on [3H]paroxetine binding in the cerebral cortex and dorsal hippocampus of gonadectomized male and female rats , 1993, Brain Research.

[45]  L. D. van de Kar,et al.  Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus. , 1982, Neuroendocrinology.

[46]  M. Vincens,et al.  Differential effects of exogenous oestradiol and progesterone on mood in post-menopausal women: individual dose/effect relationship. , 1982, Maturitas.

[47]  C. Clarke.  Cell-specific regulation of progesterone receptor in the female reproductive system , 1990, Molecular and Cellular Endocrinology.

[48]  H. C. Hartzell,et al.  Molecular physiology of norepinephrine and serotonin transporters. , 1994, The Journal of experimental biology.

[49]  M. Caron,et al.  Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids , 1996, Brain Research.

[50]  R. Brenner,et al.  Hormonal regulation of the reproductive tract in female mammals. , 1975, Annual review of physiology.

[51]  R. Brenner,et al.  Estrogen and progestin receptor immunocytochemistry in lactotropes versus gonadotropes of monkey pituitary cell cultures. , 1989, Endocrinology.

[52]  E. Eriksson,et al.  The Serotonin Reuptake Inhibitor Paroxetin Is Superior to the Noradrenaline Reuptake Inhibitor Maprotiline in the Treatment of Premenstrual Syndrome , 1995, Neuropsychopharmacology.

[53]  C. Bethea,et al.  Immunocytochemical localization of progestin receptors in monkey hypothalamus: effect of estrogen and progestin. , 1992, Endocrinology.